BamSEC and AlphaSense Join Forces
Learn More

TherapeuticsMD Inc.

NASDAQ: TXMD    
Share price (11/21/24): $1.33    
Market cap (11/21/24): $58.1 million

Material Contracts Filter

EX-10.1
from 10-Q 15 pages Master Services Agreement
12/34/56
EX-10.48
from 10-K 2 pages Amendment to Employment Agreement
12/34/56
EX-10.47
from 10-K 21 pages Amended and Restated Employment Agreement
12/34/56
EX-10.46
from 10-K 3 pages Amendment No. 1 to the Transaction Agreement Between Mayne Pharma LLC and Therapeuticsmd, Inc
12/34/56
EX-10.45
from 10-K 4 pages Amendment No. 1 to the License Agreement Between Mayne Pharma LLC and Therapeuticsmd, Inc
12/34/56
EX-10.2
from 8-K 13 pages General Consulting and Services Agreement
12/34/56
EX-10.1
from 8-K 4 pages Second Amendment to Employment Agreement
12/34/56
EX-10.2
from 8-K 61 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.1
from 8-K 22 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.4
from 10-Q 6 pages Amendment No. 15 to Financing Agreement
12/34/56
EX-10.3
from 10-Q 6 pages Amendment No. 14 to Financing Agreement
12/34/56
EX-10.2
from 10-Q 7 pages Amendment No. 13 to Financing Agreement
12/34/56
EX-10.1
from 10-Q 7 pages Amendment No. 12 to Financing Agreement
12/34/56
EX-10.2
from 8-K 39 pages Subscription Agreement
12/34/56
EX-10.1
from 8-K 27 pages Subscription Agreement
12/34/56
EX-10.2
from 8-K 39 pages Subscription Agreement
12/34/56
EX-10.1
from 8-K 27 pages Subscription Agreement
12/34/56
EX-10.3
from 8-K 8 pages Amendment No. 16 to Financing Agreement
12/34/56
EX-10.2
from 8-K 37 pages Subscription Agreement
12/34/56
EX-10.1
from 8-K 29 pages Subscription Agreement
12/34/56